New human data hints at psychedelics’ potential to combat inflammation

Researchers are publishing some of the first data in humans that signals psilocybin holds potential for patients with neurodegenerative diseases.

Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson’s disease.

(Image credit: Cannabis-Pic)